Pharmaceuticals company Gujarat Themis Biosyn announced Q3FY26 results Revenue: Rs 4,336.82 lakh against Rs 3,951.98 lakh during Q3FY25, change 10%. PBT: Rs 1,687.34 lakh against Rs 1,740.04 lakh during Q3FY25, change -3%. PAT: Rs 1,246.46 lakh against Rs 1,297.23 lakh during Q3FY25, change -4%. EPS: Rs 1.14 for Q3FY26. Result PDF